Ligand Pharmaceuticals Inc (LGND)
Short-Term Debt
$1.08M
Quarterly · Period ending: · USD
LGND Short-Term Debt
Latest reported$1.08Mperiod ending
Latest reported$1.08Mperiod ending
LGND Quarterly Short-Term Debt ($1.20M → $1.08M)
Quarterly short-term debt
High-resolution chart · PNG
LGND short-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Short-Term Debt (USD) |
|---|---|
| 1,082,000 | |
| 1,088,000 | |
| 1,095,000 | |
| 1,089,000 | |
| 1,113,000 | |
| 883,000 | |
| 1,290,000 | |
| 1,090,000 | |
| 1,168,000 | |
| 1,003,000 | |
| 410,000 | |
| 497,000 | |
| 680,000 | |
| 77,493,000 | |
| 77,410,000 | |
| 78,993,000 | |
| 117,525,000 | |
| 1,902,000 | |
| 1,413,000 | |
| 2,226,000 | |
| 2,320,000 | |
| 7,610,000 | |
| 8,478,000 | |
| 1,029,000 | |
| 1,728,000 | |
| 1,483,000 | |
| 1,255,000 | |
| 926,000 | |
| 28,076,000 | |
| 27,943,000 | |
| 26,433,000 | |
| 213,144,000 | |
| 210,370,000 | |
| 227,547,000 | |
| 227,648,000 | |
| 221,557,000 | |
| 218,630,000 | |
| 215,748,000 | |
| 212,910,000 | |
| 210,115,000 | |
| 207,363,000 | |
| 0 | |
| 201,985,000 | |
| 0 | |
| 0 | |
| 348,000 | |
| 0 | |
| 337,000 | |
| 2,698,000 | |
| 5,769,000 | |
| 9,109,000 | |
| 12,375,000 | |
| 13,600,000 | |
| 13,212,000 | |
| 14,835,000 | |
| 13,259,000 | |
| 15,294,000 | |
| 6,096,000 | |
| 10,000,000 | |
| 18,030,000 | |
| 10,000,000 | |
| 10,300,000 | |
| 0 | |
| 15,072,000 | |
| 19,602,000 | |
| 4,574,000 | |
| 91,000 | |
| 12,097,000 | |
| 11,759,000 | |
| 11,546,000 | |
| 3,658,000 | |
| 716,000 | |
| 978,000 | |
| 1,238,000 | |
| 1,528,000 | |
| 1,810,000 | |
| 1,989,000 | |
| 2,151,000 | |
| 37,750,000 | |
| 363,000 | |
| 2,502,000 | |
| 2,648,000 | |
| 2,745,000 | |
| 2,825,000 | |
| 2,969,000 | |
| 2,976,000 | |
| 2,924,000 | |
| 2,931,000 | |
| 2,756,000 | |
| 2,742,000 | |
| 2,479,000 | |
| 0 | |
| 6,016,000 | |
| 2,105,000 | |
| 2,087,000 | |
| 8,908,000 | |
| 5,092,000 | |
| 53,131,000 | |
| 5,367,000 | |
| 2,551,000 |